DaVita

Recent news

• Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $250
  Market Newswire · 2026/7/14
• Rating change
  TD Cowen Upgrades DaVita(DVA.US) to Buy Rating, Raises Target Price to $220
  Market Newswire · 2026/8/7
• Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $215
  Market Newswire · 2026/8/7
• Rating change
  TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $201
  Market Newswire · 2026/5/11
• Company notice
  DaVita | 4: Statement of changes in beneficial ownership of securities-Director Moore Gregory J.
  SEC · 2026/5/19
• Rating change
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and DaVita (DVA)
  TipRanks · 2026/8/5
• Company notice
  DaVita | 4: Statement of changes in beneficial ownership of securities-Director Hollar Jason M.
  SEC · 2026/3/18
• Rating change
  Deutsche Bank Maintains DaVita(DVA.US) With Buy Rating, Raises Target Price to $265
  Market Newswire · 2026/8/5
• Rating change
  Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $224
  Market Newswire · 2026/8/11
• At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?
  Simply Wall St · 2026/8/27
• Rating change
  TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $201
  Market Newswire · 2026/5/11
• Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $215
  Market Newswire · 2026/8/13
• Company notice
  DaVita | 4: Statement of changes in beneficial ownership of securities-Director Moore Gregory J.
  SEC · 2025/11/18
• Company notice
  DaVita | 4: Statement of changes in beneficial ownership of securities-Director Hollar Jason M.
  SEC · 2026/5/19
• Rating change
  Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $205
  Market Newswire · 2026/5/8
• Rating change
  Truist Financial Maintains DaVita(DVA.US) With Hold Rating
  Market Newswire · 2026/8/5
• Rating change
  Daon Shares (002838): Consolidation synergies drive a sharp earnings surge; DVA commercialization enters the realization phase.
  Changjiang Securities · 2026/8/31
• UBS Maintains DaVita(DVA.US) With Buy Rating, Raises Target Price to $270
  Market Newswire · 2026/7/10
• Rating change
  BofA Securities Maintains DaVita(DVA.US) With Sell Rating
  Market Newswire · 2026/8/5
• Company notice
  DaVita | 4: Statement of changes in beneficial ownership of securities-Director Moore Gregory J.
  SEC · 2026/3/18

Headlines are aggregated automatically and are not independently verified or edited by our team.